Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Daily Intelligence Tracker
    • Plans Blog Contact
    AngioDynamics Inc logo
    ANGO

    AngioDynamics Inc

    MaveScore 27 Low model confidence
    Last Price US$12.78 As of Jul 10, 2026
    Market Cap US$545.6m Company size context
    7D Performance -2.37% Past 7 days
    1Y Performance 34.95% Past 12 months
    Model Rating
    Historical model output for research review

    Fundamental data date

    Feb 28, 2026

    133 days old

    Market price date

    Jul 10, 2026

    1 day old

    Coverage

    16/16

    No missing model inputs

    Data quality

    Excellent

    Current stored snapshot

    Transparent research score

    Why the model scores this stock

    MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

    MaveScore 27 Low confidence

    Stored data quality

    Freshness and coverage checks

    16/16 Current stored snapshot

    Quality

    9/35 Weak

    Blends latest model rank with profitability and dilution ranks.

    Financial Strength

    4/25 Weak

    Rewards durable profitability, margins, and positive free cash flow.

    Valuation Support

    3/15 Weak

    Favors positive earnings, positive cash flow, and lower multiples.

    Momentum

    11/15 Strong

    Highlights research candidates with supportive 3-month and 6-month price regimes.

    Shareholder Alignment

    0/10 Weak

    Rewards less dilutive share behavior and enough size for liquid research coverage.

    Positive model output

    • Highlights research candidates with supportive 3-month and 6-month price regimes.

    Research risks to review

    • Blends latest model rank with profitability and dilution ranks.
    • Rewards durable profitability, margins, and positive free cash flow.
    • Favors positive earnings, positive cash flow, and lower multiples.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    AngioDynamics Inc Overview

    Industry: Medical Instruments & Supplies

    Sector: Healthcare

    AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationall Read More

    AngioDynamics Inc is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

    AngioDynamics Inc

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Apr 02, 2026

    Quarterly result summary

    Net sales was $78.4 (reported); EPS was $0.3 (reported).

    Net sales $78.4 reported
    EPS $0.3 reported

    What changed

    • Net sales reported to $78.4; EPS reported to $0.3.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings material Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Apr 02, 2026 SEC filing 8-K Apr 02, 2026 Earnings release EXHIBIT 99.1 Apr 02, 2026 SEC filing 10-Q Jan 06, 2026 SEC filing 8-K Jan 06, 2026 Earnings release EXHIBIT 99.1 Jan 06, 2026 Earnings material EXHIBIT 99.2 Jan 06, 2026 Earnings release EXHIBIT 99.1 Oct 02, 2025 Earnings material EXHIBIT 99.2 Oct 02, 2025 SEC filing 10-Q Oct 02, 2025 SEC filing 8-K Oct 02, 2025

    Recent News



    AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines
    1 hour ago
    AngioDynamics Reports Growth and Advances NanoKnife System
    6 hours ago
    Institutional investors are AngioDynamics, Inc.'s (NASDAQ:ANGO) biggest bettors and were rewarded after last week's US$154m market cap gain
    2 hours ago

    Earnings Per Share

    Score 2.00/5
    AngioDynamics Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Instruments & Supplies industry , West Pharmaceutical Services Inc , Hologic Inc , Haemonetics are companies with high ratings.

    Return on Equity

    Score 1.03/5
    AngioDynamics Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    AngioDynamic... ANGO US$545.6m
    Zoetis Inc ZTS US$31.4b
    IQVIA Holdin... IQV US$34.6b
    Agilent Tech... A US$36.9b

    Net Margin

    Score 2.12/5
    AngioDynamics Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    AngioDynamic... ANGO US$545.6m
    Zoetis Inc ZTS US$31.4b
    IQVIA Holdin... IQV US$34.6b
    Agilent Tech... A US$36.9b

    Share Buyback

    In Medical Instruments & Supplies industry , West Pharmaceutical Services Inc , Hologic Inc , Haemonetics are companies with high ratings.

    Leverage

    Score 3.01/5
    AngioDynamics Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
    AngioDynamic... ANGO US$545.6m
    Zoetis Inc ZTS US$31.4b
    IQVIA Holdin... IQV US$34.6b
    Agilent Tech... A US$36.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    SEC financial statements are temporarily unavailable.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    AngioDynamics Inc logo

    AngioDynamics Inc

    US$12.78

    US$545.6m

    -2.37%

    34.95%